Abstract
Background and Aims : Background. Patients with Familial hypercholesterolemia are a group of high cardiovascular risk, they require multiple lipid-lowering treatments and has difficulty reaching therapeutic goals. PCSK9i are currently a treatment option. Aim. To evaluate the achievement of therapeutic goals in a group of patients with familial hypercholesterolemia under PCSK9 inhibitors treatment.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
